CYP2C19 and major depressive disorder: CRBP1, RDH10—one of the enzymes involved in the first of the two-step oxidation from ROL to at-RA—and one of the RA catabolizing enzymes, CYP2C19, were increased in female MDD patients compared to female controls, suggesting increased turnover of both at-RA and its substrate ROL.